Ceftriaxone versus cefazolin for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia

Adham Mohamed,Nicholas Bennett,Jeannette Ploetz,Laura Aragon,Kevin Kennedy,Sarah Boyd

International Journal of Antimicrobial Agents（2022）

引用 4|浏览7

暂无评分

摘要

•Few studies have evaluated inpatient use of ceftriaxone for MSSA bacteraemia.•This retrospective multicentre study included adults with MSSA bacteraemia.•Study compared ceftriaxone versus cefazolin for treatment of MSSA bacteraemia.•No difference in rates of clinical cure between the two treatment groups.•No difference in secondary or safety outcomes between the two treatment groups.

查看译文

关键词

Bacteraemia,Methicillin-susceptible Staphylococcus aureus,MSSA,Ceftriaxone,Cefazolin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要